Enliven Therapeutics, Inc. (ELVN)
47.54
-1.26
(-2.58%)
USD |
NASDAQ |
Nov 16, 16:00
47.54
0.00 (0.00%)
After-Hours: 20:00
Enliven Therapeutics Price : 47.54 for Nov. 16, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 48.22 | 49.13 | 46.96 | 48.80 | 972567.0 |
| Nov 12, 2026 | 50.69 | 50.76 | 48.02 | 48.31 | 917127.0 |
| Nov 11, 2026 | 51.46 | 52.23 | 51.01 | 51.19 | 781466.0 |
| Nov 10, 2026 | 50.08 | 51.80 | 49.74 | 51.20 | 951735.0 |
| Nov 09, 2026 | 49.88 | 51.86 | 48.76 | 51.55 | 697165.0 |
| Nov 06, 2026 | 46.19 | 49.66 | 44.55 | 49.43 | 969794.0 |
| Nov 05, 2026 | 47.10 | 47.73 | 44.60 | 44.79 | 1.586M |
| Nov 04, 2026 | 45.74 | 47.31 | 44.21 | 47.25 | 2.707M |
| Nov 03, 2026 | 45.25 | 45.90 | 44.64 | 44.83 | 2.126M |
| Nov 02, 2026 | 44.48 | 45.06 | 43.22 | 44.63 | 1.139M |
| Oct 30, 2026 | 44.92 | 45.87 | 44.09 | 44.25 | 1.237M |
| Oct 29, 2026 | 45.29 | 45.72 | 44.44 | 45.08 | 909463.0 |
| Oct 28, 2026 | 43.69 | 44.94 | 43.39 | 44.78 | 1.261M |
| Oct 27, 2026 | 41.80 | 44.37 | 41.52 | 43.69 | 3.308M |
| Oct 26, 2026 | 41.58 | 42.18 | 40.90 | 41.49 | 2.323M |
| Oct 23, 2026 | 41.49 | 41.64 | 40.82 | 41.52 | 2.299M |
| Oct 22, 2026 | 41.55 | 42.87 | 41.06 | 41.93 | 2.325M |
| Oct 21, 2026 | 41.76 | 42.92 | 41.58 | 41.82 | 2.053M |
| Oct 20, 2026 | 38.86 | 41.36 | 38.41 | 41.25 | 1.938M |
| Oct 19, 2026 | 38.01 | 38.83 | 37.50 | 38.70 | 1.312M |
| Oct 16, 2026 | 39.33 | 39.46 | 36.96 | 37.32 | 1.188M |
| Oct 15, 2026 | 39.48 | 40.29 | 38.49 | 39.33 | 2.054M |
| Oct 14, 2026 | 38.99 | 39.95 | 38.51 | 39.28 | 1.217M |
| Oct 13, 2026 | 40.56 | 40.99 | 39.27 | 39.49 | 847875.0 |
| Oct 12, 2026 | 40.67 | 41.41 | 40.50 | 40.84 | 579824.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Definium Therapeutics, Inc. | 30.14 |
| Cocrystal Pharma, Inc. | 0.98 |
| CNBX Pharmaceuticals, Inc. | 0.0001 |
| GB Sciences, Inc. | 0.0001 |
| Arvinas, Inc. | 6.76 |
Price Related Metrics
| Price to Book Value | 3.988 |
| Earnings Yield | -3.57% |
| Market Cap | 3.497B |